VistaRx

Visit our website to learn how we help healthcare operators capture revenue and manage data with ease and independence. vistarx.com

2025, here we come!

2024 has been an incredible year for Vista. We set new records. We were busy improving our core services and developing a new technology that will provide an industry-wide solution for long-term care. We'll be sharing more about this in 2025, so stay tuned! We'd like to take this time to thank all of our wonderful partners, new clients, and old connections. To everyone we met at this year's conferences, thank you for your time, your insights, and enlightening ideas. We're looking forward to kicking off the new year with a big push, helping our clients gain more independence, do more with their pharmacy data, and truly streamline revenue capture and claims management. As we've mentioned before—Vista is all about creating ways for our clients to ensure high-quality outcomes work for the long run. We're here for you for the years ahead, not just next quarter's reporting.

Vista is actively working on a solution that will prevent incorrect billing. This will alleviate the financial strain LTC operators are left to bear due to data that's out of sync among care partners. #Longtermcare #HealthTech #Healthcare

Need some holiday reading to get you in gear for the new year? Read our must-read round-up of the top news from across healthcare and pharma. #Healthcare #Healthtech #Medicare #Pharmacy

Simply brilliant solutions for long-term care, infusion centers, and PBMs. Do more with your data and capture more revenue. #VistaRx #Longtermcare #Healthcare

HHS will soon begin negotiating a “maximum fair price” for single-source Part B drugs, likely lower than ASP. Run an infusion center? Read on. 💉Infusion centers and provider-administered drugs will see lower reimbursement, while 340B hospitals will still see higher comparable rates. 🏥 Commercial payers, however, still favor infusion centers (in certain markets) due to the lower cost of care. Depending on the payer and contract, hospitals are still seeing significantly higher rates compared to non-hospital-based settings. 🏡 One of the lowest-cost sites for specialty drugs remains the home, but the convenience element may not outperform the clinical benefits of being in another setting. 📊 Buy-and-bill remains a robust and convenient way for infusion centers (especially those not affiliated with a health system) to receive appropriate reimbursement for specialty drug administration. It also helps save payers on their net spend. Want to make your infusion center's buy-and-bill model to achieve long-term success? Contact our experts to learn how we make data capture and management a breeze, meaning more complete billing cycles and better reimbursements. vistarx.com/contact #Pharmacy #VistaRx #Medicare #Healthcare

In many of the discussions we've had with LTC operators, incorrect billing is a major issue impacting facilities' bottom line. To that end, we're listening and working on a fix that will eliminate these fees for your facilities. #Longtermcare #HealthTech #Healthcare

Have a restful Thanksgiving! And remember, it's ok to leave some leftovers ;) #Thanksgiving

ICYMI our new website helps pharmacies and PBMs learn how they can capture and manage their pharmacy data with ease and convenience.